BD To Acquire Bard For $24 Billion | 食品添加物合法業者資訊網

通过改善医学发现方法. Read More

At BD, we seek to usher in a new era of healthcare by bringing medical products, capabilities and solutions to every corner of the world. Read More

BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving ... BD acquires C. R. Bard. Read More

BD Statement on COVID-19 (Coronavirus) ... BD releases its 2016 sustainability report, describing the progress we have ... BD completes Bard acquisition ... Read More

BD bietet ein umfassendes Portfolio an IV-Kathetern für unterschiedliche Anwendungen. Mehr. BD PosiFlush™ Spülsytem für IV-Zugangssysteme. Es minimiert das ... Read More

2017年12月29日 — The transaction builds on BD's leadership in medication management and infection prevention with an expanded offering of solutions across the ... Read More

2017年4月23日 — BD To Acquire Bard For $24 Billion ; $317.00 per Bard common share in cash and stock, for a total consideration of ; $24 billion . The agreement ... Read More

We are BD, a global medical company. ... If you are concerned that an offer of employment with BD, CareFusion or C.R. Bard might be a scam, please verify by ... Read More

我們的醫療科技領域上占有領導之地位，巴德(Bard)及其產品於2017年加入BD家族，共同提供前瞻性的的健康解決方案。 傑出、友善、合作的夥伴及團隊，絕佳的工作環境. Read More